Zydus Lifesciences to commercialize OncoStem’s CanAssist Breast test

Zydus Lifesciences has secured exclusive marketing rights to CanAssist Breast, a prognostic test for breast cancer patients in the early stages, from Bengaluru-based OncoStem. According ... Read More